1. Home
  2. DYN vs NYAX Comparison

DYN vs NYAX Comparison

Compare DYN & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • NYAX
  • Stock Information
  • Founded
  • DYN 1984
  • NYAX 2005
  • Country
  • DYN United States
  • NYAX Israel
  • Employees
  • DYN N/A
  • NYAX N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • NYAX
  • Sector
  • DYN Health Care
  • NYAX
  • Exchange
  • DYN Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • DYN 1.3B
  • NYAX 1.5B
  • IPO Year
  • DYN 2020
  • NYAX N/A
  • Fundamental
  • Price
  • DYN $14.70
  • NYAX $44.78
  • Analyst Decision
  • DYN Strong Buy
  • NYAX Buy
  • Analyst Count
  • DYN 13
  • NYAX 6
  • Target Price
  • DYN $45.92
  • NYAX $38.33
  • AVG Volume (30 Days)
  • DYN 2.0M
  • NYAX 17.6K
  • Earning Date
  • DYN 05-08-2025
  • NYAX 05-13-2025
  • Dividend Yield
  • DYN N/A
  • NYAX N/A
  • EPS Growth
  • DYN N/A
  • NYAX N/A
  • EPS
  • DYN N/A
  • NYAX N/A
  • Revenue
  • DYN N/A
  • NYAX $314,013,000.00
  • Revenue This Year
  • DYN N/A
  • NYAX $33.44
  • Revenue Next Year
  • DYN N/A
  • NYAX $23.74
  • P/E Ratio
  • DYN N/A
  • NYAX N/A
  • Revenue Growth
  • DYN N/A
  • NYAX 33.34
  • 52 Week Low
  • DYN $6.36
  • NYAX $20.31
  • 52 Week High
  • DYN $47.45
  • NYAX $46.13
  • Technical
  • Relative Strength Index (RSI)
  • DYN 72.20
  • NYAX 59.20
  • Support Level
  • DYN $13.14
  • NYAX $44.00
  • Resistance Level
  • DYN $12.34
  • NYAX $46.13
  • Average True Range (ATR)
  • DYN 0.79
  • NYAX 1.08
  • MACD
  • DYN 0.23
  • NYAX 0.11
  • Stochastic Oscillator
  • DYN 91.82
  • NYAX 82.31

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: